Summary of Study ST002383

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001533. The data can be accessed directly via it's Project DOI: 10.21228/M8J99C This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST002383
Study TitleMetabolomics of B-cell Acute Lymphoblastic Leukemia in Response to Adipocyte Conditioned Media
Study TypeUntargeted MS
Study SummaryAdipocyte conditioned media (ACM), stromal cell conditioned media (SCM) and unconditioned media (UCM) were added to B-cell Acute Lymphoblastic Leukemia cells (REH and RCH-AcV) either with or without methotrexate (MTX). The metabolomic profiles of the cells was determined by mass spectrometry.
Institute
Emory University
DepartmentPediatrics
LaboratoryJoshua Chandler, PhD
Last NameChandler
First NameJoshua
Address2015 Uppergate Drive NE, Atlanta, GA 30322
Emailjoshua.chandler@emory.edu
Phone404-727-3536
Submit Date2022-10-07
Num GroupsTwo sets of two sets of three groups (MTX and no-MTX, REH and RCH-AcV, ACM vs SCM vs UCM)
Total Subjects3 replicates of each group (36 total)
Publicationssubmitted to JNCI
Raw Data AvailableYes
Raw Data File Type(s)mzML
Analysis Type DetailLC-MS
Release Date2023-06-07
Release Version1
Joshua Chandler Joshua Chandler
https://dx.doi.org/10.21228/M8J99C
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Collection:

Collection ID:CO002465
Collection Summary:Human B-ALL cell lines (REH and RCH-AcV) were cultured for 24 hours in UCM, SCM, or ACM. Additionally, MTX-treated human B-ALL cells were cultured for an additional 12 hours of treatment with MTX (50nM for REH and 70 nM for RCH-AcV). This timepoint was chosen due to our prior work in this system to avoid submitting mostly apoptotic cells for analysis [18]. After the prescribed time, leukemia cells were harvested for analysis. Notably, cell viability at the time of harvest exceeded 85% in each culture (n=3 biological replicates). Cell viability was measured using cell a Bio-Rad cell counter (cat#TC20, Bio-Rad, Hercules, CA) and over 1 million viable cells were collected and washed with 1X cold PBS (pH7.4). Cell pellets were snap-frozen in dry ice and stored at -80oC until samples were submitted to our core facility.
Sample Type:B cells
Storage Conditions:-80℃
  logo